Cullinan Therapeutics, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Cullinan Therapeutics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $0.00 for the year ending 2022.

  • Cullinan Therapeutics, Inc. showed a decrease of -100.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2021 to 2022.
  • This data is from Cullinan Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2023.
  • XBRL data for this metric is available from 2020 to 2022 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2022: $0.00 | Fiscal year 2021: $18.94 million | Fiscal year 2020: $0.00.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: